APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pemetrexed Diacid

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Pemetrexed Diacid Market Analysis and Forecast 2026-2032

21 December 2025195 pages

Choose your research edition.

Industry ResearchPemetrexed Diacid Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Pemetrexed Diacid Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Pemetrexed Diacid Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pemetrexed Diacid Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Pemetrexed Diacid Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Pemetrexed Diacid market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Pemetrexed Diacid is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Pemetrexed Diacid is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Pemetrexed Diacid is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Pemetrexed Diacid is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Pemetrexed Diacid include Qilu Pharma, Nanjing Pharmaceutical Factory Co., Ltd., Lianyungang Tengfa Bio-tech Co., Ltd., Eli Lilly and Company, United Biotech India Pvt.Ltd., Pemgem, Onkos, Natco Pharma Ltd and Emcure, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Pemetrexed Diacid, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Pemetrexed Diacid, also provides the sales of main regions and countries. Of the upcoming market potential for Pemetrexed Diacid, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pemetrexed Diacid sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pemetrexed Diacid market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Pemetrexed Diacid sales, projected growth trends, production technology, application and end-user industry.

Pemetrexed Diacid Segment by Company

Qilu Pharma

Nanjing Pharmaceutical Factory Co., Ltd.

Lianyungang Tengfa Bio-tech Co., Ltd.

Eli Lilly and Company

United Biotech India Pvt.Ltd.

Pemgem

Onkos

Natco Pharma Ltd

Emcure

Cytotoxic

ChemOthersapy

Beacon Pharma

Actiza Parma

Pemetrexed Diacid Segment by Type

500mg Injection

300mg Injection

200mg Injection

100mg Injection

Pemetrexed Diacid Segment by Application

Mesothelioma

Non-Small Cell Lung Cancer

Others

Pemetrexed Diacid Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pemetrexed Diacid market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pemetrexed Diacid and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pemetrexed Diacid.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Pemetrexed Diacid in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Pemetrexed Diacid manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pemetrexed Diacid sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pemetrexed Diacid Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 500mg Injection Major Manufacturers Table 3. 300mg Injection Major Manufacturers Table 4. 200mg Injection Major Manufacturers Table 5. 100mg Injection Major Manufacturers Table 6. Global Pemetrexed Diacid Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Mesothelioma Major Manufacturers Table 8. Non-Small Cell Lung Cancer Major Manufacturers Table 9. Others Major Manufacturers Table 10. Pemetrexed Diacid Industry Trends Table 11. Pemetrexed Diacid Industry Drivers Table 12. Pemetrexed Diacid Industry Opportunities and Challenges Table 13. Pemetrexed Diacid Industry Restraints Table 14. Global Pemetrexed Diacid Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Pemetrexed Diacid Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Pemetrexed Diacid Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Pemetrexed Diacid Revenue Market Share by Region (2021-2026) Table 18. Global Pemetrexed Diacid Revenue Market Share by Region (2027-2032) Table 19. Global Pemetrexed Diacid Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (doses) Table 20. Global Pemetrexed Diacid Sales by Region (2021-2026) & (doses) Table 21. Global Pemetrexed Diacid Sales by Region (2027-2032) & (doses) Table 22. Global Pemetrexed Diacid Sales Market Share by Region (2021-2026) Table 23. Global Pemetrexed Diacid Sales Market Share by Region (2027-2032) Table 24. Global Pemetrexed Diacid Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Pemetrexed Diacid Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Pemetrexed Diacid Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Pemetrexed Diacid Sales Market Share by Manufacturers (2021-2026) Table 28. Global Pemetrexed Diacid Sales Price (US$/dose) of Manufacturers (2021-2026) Table 29. Global Pemetrexed Diacid Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Pemetrexed Diacid Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Pemetrexed Diacid Manufacturers, Product Type & Application Table 32. Global Pemetrexed Diacid Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Pemetrexed Diacid by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Pemetrexed Diacid Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Pemetrexed Diacid Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Pemetrexed Diacid Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Pemetrexed Diacid Revenue Market Share by Type (2021-2026) Table 39. Global Pemetrexed Diacid Revenue Market Share by Type (2027-2032) Table 40. Global Pemetrexed Diacid Sales by Type 2021 VS 2025 VS 2032 (doses) Table 41. Global Pemetrexed Diacid Sales by Type (2021-2026) & (doses) Table 42. Global Pemetrexed Diacid Sales by Type (2027-2032) & (doses) Table 43. Global Pemetrexed Diacid Sales Market Share by Type (2021-2026) Table 44. Global Pemetrexed Diacid Sales Market Share by Type (2027-2032) Table 45. Global Pemetrexed Diacid Price by Type (2021-2026) & (US$/dose) Table 46. Global Pemetrexed Diacid Price by Type (2027-2032) & (US$/dose) Table 47. Global Pemetrexed Diacid Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Pemetrexed Diacid Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Pemetrexed Diacid Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Pemetrexed Diacid Revenue Market Share by Application (2021-2026) Table 51. Global Pemetrexed Diacid Revenue Market Share by Application (2027-2032) Table 52. Global Pemetrexed Diacid Sales by Application 2021 VS 2025 VS 2032 (doses) Table 53. Global Pemetrexed Diacid Sales by Application (2021-2026) & (doses) Table 54. Global Pemetrexed Diacid Sales by Application (2027-2032) & (doses) Table 55. Global Pemetrexed Diacid Sales Market Share by Application (2021-2026) Table 56. Global Pemetrexed Diacid Sales Market Share by Application (2027-2032) Table 57. Global Pemetrexed Diacid Price by Application (2021-2026) & (US$/dose) Table 58. Global Pemetrexed Diacid Price by Application (2027-2032) & (US$/dose) Table 59. Qilu Pharma Company Information Table 60. Qilu Pharma Business Overview Table 61. Qilu Pharma Pemetrexed Diacid Sales (doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 62. Qilu Pharma Pemetrexed Diacid Product Portfolio Table 63. Qilu Pharma Recent Development Table 64. Nanjing Pharmaceutical Factory Co., Ltd. Company Information Table 65. Nanjing Pharmaceutical Factory Co., Ltd. Business Overview Table 66. Nanjing Pharmaceutical Factory Co., Ltd. Pemetrexed Diacid Sales (doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 67. Nanjing Pharmaceutical Factory Co., Ltd. Pemetrexed Diacid Product Portfolio Table 68. Nanjing Pharmaceutical Factory Co., Ltd. Recent Development Table 69. Lianyungang Tengfa Bio-tech Co., Ltd. Company Information Table 70. Lianyungang Tengfa Bio-tech Co., Ltd. Business Overview Table 71. Lianyungang Tengfa Bio-tech Co., Ltd. Pemetrexed Diacid Sales (doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 72. Lianyungang Tengfa Bio-tech Co., Ltd. Pemetrexed Diacid Product Portfolio Table 73. Lianyungang Tengfa Bio-tech Co., Ltd. Recent Development Table 74. Eli Lilly and Company Company Information Table 75. Eli Lilly and Company Business Overview Table 76. Eli Lilly and Company Pemetrexed Diacid Sales (doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 77. Eli Lilly and Company Pemetrexed Diacid Product Portfolio Table 78. Eli Lilly and Company Recent Development Table 79. United Biotech India Pvt.Ltd. Company Information Table 80. United Biotech India Pvt.Ltd. Business Overview Table 81. United Biotech India Pvt.Ltd. Pemetrexed Diacid Sales (doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 82. United Biotech India Pvt.Ltd. Pemetrexed Diacid Product Portfolio Table 83. United Biotech India Pvt.Ltd. Recent Development Table 84. Pemgem Company Information Table 85. Pemgem Business Overview Table 86. Pemgem Pemetrexed Diacid Sales (doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 87. Pemgem Pemetrexed Diacid Product Portfolio Table 88. Pemgem Recent Development Table 89. Onkos Company Information Table 90. Onkos Business Overview Table 91. Onkos Pemetrexed Diacid Sales (doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 92. Onkos Pemetrexed Diacid Product Portfolio Table 93. Onkos Recent Development Table 94. Natco Pharma Ltd Company Information Table 95. Natco Pharma Ltd Business Overview Table 96. Natco Pharma Ltd Pemetrexed Diacid Sales (doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 97. Natco Pharma Ltd Pemetrexed Diacid Product Portfolio Table 98. Natco Pharma Ltd Recent Development Table 99. Emcure Company Information Table 100. Emcure Business Overview Table 101. Emcure Pemetrexed Diacid Sales (doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 102. Emcure Pemetrexed Diacid Product Portfolio Table 103. Emcure Recent Development Table 104. Cytotoxic Company Information Table 105. Cytotoxic Business Overview Table 106. Cytotoxic Pemetrexed Diacid Sales (doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 107. Cytotoxic Pemetrexed Diacid Product Portfolio Table 108. Cytotoxic Recent Development Table 109. ChemOthersapy Company Information Table 110. ChemOthersapy Business Overview Table 111. ChemOthersapy Pemetrexed Diacid Sales (doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 112. ChemOthersapy Pemetrexed Diacid Product Portfolio Table 113. ChemOthersapy Recent Development Table 114. Beacon Pharma Company Information Table 115. Beacon Pharma Business Overview Table 116. Beacon Pharma Pemetrexed Diacid Sales (doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 117. Beacon Pharma Pemetrexed Diacid Product Portfolio Table 118. Beacon Pharma Recent Development Table 119. Actiza Parma Company Information Table 120. Actiza Parma Business Overview Table 121. Actiza Parma Pemetrexed Diacid Sales (doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 122. Actiza Parma Pemetrexed Diacid Product Portfolio Table 123. Actiza Parma Recent Development Table 124. North America Pemetrexed Diacid Revenue by Type (2021-2026) & (US$ Million) Table 125. North America Pemetrexed Diacid Revenue by Type (2027-2032) & (US$ Million) Table 126. North America Pemetrexed Diacid Sales by Type (2021-2026) & (doses) Table 127. North America Pemetrexed Diacid Sales by Type (2027-2032) & (doses) Table 128. North America Pemetrexed Diacid Sales Price by Type (2021-2026) & (US$/dose) Table 129. North America Pemetrexed Diacid Sales Price by Type (2027-2032) & (US$/dose) Table 130. North America Pemetrexed Diacid Revenue by Application (2021-2026) & (US$ Million) Table 131. North America Pemetrexed Diacid Revenue by Application (2027-2032) & (US$ Million) Table 132. North America Pemetrexed Diacid Sales by Application (2021-2026) & (doses) Table 133. North America Pemetrexed Diacid Sales by Application (2027-2032) & (doses) Table 134. North America Pemetrexed Diacid Sales Price by Application (2021-2026) & (US$/dose) Table 135. North America Pemetrexed Diacid Sales Price by Application (2027-2032) & (US$/dose) Table 136. North America Pemetrexed Diacid Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 137. North America Pemetrexed Diacid Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 138. North America Pemetrexed Diacid Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 139. North America Pemetrexed Diacid Sales by Country (2021 VS 2025 VS 2032) & (doses) Table 140. North America Pemetrexed Diacid Sales by Country (2021-2026) & (doses) Table 141. North America Pemetrexed Diacid Sales by Country (2027-2032) & (doses) Table 142. North America Pemetrexed Diacid Sales Price by Country (2021-2026) & (US$/dose) Table 143. North America Pemetrexed Diacid Sales Price by Country (2027-2032) & (US$/dose) Table 144. United States Pemetrexed Diacid Revenue (2021-2032) & (US$ Million) Table 145. Canada Pemetrexed Diacid Revenue (2021-2032) & (US$ Million) Table 146. Mexico Pemetrexed Diacid Revenue (2021-2032) & (US$ Million) Table 147. Europe Pemetrexed Diacid Revenue by Type (2021-2026) & (US$ Million) Table 148. Europe Pemetrexed Diacid Revenue by Type (2027-2032) & (US$ Million) Table 149. Europe Pemetrexed Diacid Sales by Type (2021-2026) & (doses) Table 150. Europe Pemetrexed Diacid Sales by Type (2027-2032) & (doses) Table 151. Europe Pemetrexed Diacid Sales Price by Type (2021-2026) & (US$/dose) Table 152. Europe Pemetrexed Diacid Sales Price by Type (2027-2032) & (US$/dose) Table 153. Europe Pemetrexed Diacid Revenue by Application (2021-2026) & (US$ Million) Table 154. Europe Pemetrexed Diacid Revenue by Application (2027-2032) & (US$ Million) Table 155. Europe Pemetrexed Diacid Sales by Application (2021-2026) & (doses) Table 156. Europe Pemetrexed Diacid Sales by Application (2027-2032) & (doses) Table 157. Europe Pemetrexed Diacid Sales Price by Application (2021-2026) & (US$/dose) Table 158. Europe Pemetrexed Diacid Sales Price by Application (2027-2032) & (US$/dose) Table 159. Europe Pemetrexed Diacid Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 160. Europe Pemetrexed Diacid Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 161. Europe Pemetrexed Diacid Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 162. Europe Pemetrexed Diacid Sales by Country (2021 VS 2025 VS 2032) & (doses) Table 163. Europe Pemetrexed Diacid Sales by Country (2021-2026) & (doses) Table 164. Europe Pemetrexed Diacid Sales by Country (2027-2032) & (doses) Table 165. Europe Pemetrexed Diacid Sales Price by Country (2021-2026) & (US$/dose) Table 166. Europe Pemetrexed Diacid Sales Price by Country (2027-2032) & (US$/dose) Table 167. Germany Pemetrexed Diacid Revenue (2021-2032) & (US$ Million) Table 168. France Pemetrexed Diacid Revenue (2021-2032) & (US$ Million) Table 169. U.K. Pemetrexed Diacid Revenue (2021-2032) & (US$ Million) Table 170. Italy Pemetrexed Diacid Revenue (2021-2032) & (US$ Million) Table 171. Russia Pemetrexed Diacid Revenue (2021-2032) & (US$ Million) Table 172. Spain Pemetrexed Diacid Revenue (2021-2032) & (US$ Million) Table 173. Netherlands Pemetrexed Diacid Revenue (2021-2032) & (US$ Million) Table 174. Switzerland Pemetrexed Diacid Revenue (2021-2032) & (US$ Million) Table 175. Sweden Pemetrexed Diacid Revenue (2021-2032) & (US$ Million) Table 176. Poland Pemetrexed Diacid Revenue (2021-2032) & (US$ Million) Table 177. China Pemetrexed Diacid Revenue by Type (2021-2026) & (US$ Million) Table 178. China Pemetrexed Diacid Revenue by Type (2027-2032) & (US$ Million) Table 179. China Pemetrexed Diacid Sales by Type (2021-2026) & (doses) Table 180. China Pemetrexed Diacid Sales by Type (2027-2032) & (doses) Table 181. China Pemetrexed Diacid Sales Price by Type (2021-2026) & (US$/dose) Table 182. China Pemetrexed Diacid Sales Price by Type (2027-2032) & (US$/dose) Table 183. China Pemetrexed Diacid Revenue by Application (2021-2026) & (US$ Million) Table 184. China Pemetrexed Diacid Revenue by Application (2027-2032) & (US$ Million) Table 185. China Pemetrexed Diacid Sales by Application (2021-2026) & (doses) Table 186. China Pemetrexed Diacid Sales by Application (2027-2032) & (doses) Table 187. China Pemetrexed Diacid Sales Price by Application (2021-2026) & (US$/dose) Table 188. China Pemetrexed Diacid Sales Price by Application (2027-2032) & (US$/dose) Table 189. Asia Pemetrexed Diacid Revenue by Type (2021-2026) & (US$ Million) Table 190. Asia Pemetrexed Diacid Revenue by Type (2027-2032) & (US$ Million) Table 191. Asia Pemetrexed Diacid Sales by Type (2021-2026) & (doses) Table 192. Asia Pemetrexed Diacid Sales by Type (2027-2032) & (doses) Table 193. Asia Pemetrexed Diacid Sales Price by Type (2021-2026) & (US$/dose) Table 194. Asia Pemetrexed Diacid Sales Price by Type (2027-2032) & (US$/dose) Table 195. Asia Pemetrexed Diacid Revenue by Application (2021-2026) & (US$ Million) Table 196. Asia Pemetrexed Diacid Revenue by Application (2027-2032) & (US$ Million) Table 197. Asia Pemetrexed Diacid Sales by Application (2021-2026) & (doses) Table 198. Asia Pemetrexed Diacid Sales by Application (2027-2032) & (doses) Table 199. Asia Pemetrexed Diacid Sales Price by Application (2021-2026) & (US$/dose) Table 200. Asia Pemetrexed Diacid Sales Price by Application (2027-2032) & (US$/dose) Table 201. Asia Pemetrexed Diacid Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 202. Asia Pemetrexed Diacid Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 203. Asia Pemetrexed Diacid Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 204. Asia Pemetrexed Diacid Sales by Country (2021 VS 2025 VS 2032) & (doses) Table 205. Asia Pemetrexed Diacid Sales by Country (2021-2026) & (doses) Table 206. Asia Pemetrexed Diacid Sales by Country (2027-2032) & (doses) Table 207. Asia Pemetrexed Diacid Sales Price by Country (2021-2026) & (US$/dose) Table 208. Asia Pemetrexed Diacid Sales Price by Country (2027-2032) & (US$/dose) Table 209. Japan Pemetrexed Diacid Revenue (2021-2032) & (US$ Million) Table 210. South Korea Pemetrexed Diacid Revenue (2021-2032) & (US$ Million) Table 211. India Pemetrexed Diacid Revenue (2021-2032) & (US$ Million) Table 212. Australia Pemetrexed Diacid Revenue (2021-2032) & (US$ Million) Table 213. Taiwan Pemetrexed Diacid Revenue (2021-2032) & (US$ Million) Table 214. Southeast Asia Pemetrexed Diacid Revenue (2021-2032) & (US$ Million) Table 215. SAMEA Pemetrexed Diacid Revenue by Type (2021-2026) & (US$ Million) Table 216. SAMEA Pemetrexed Diacid Revenue by Type (2027-2032) & (US$ Million) Table 217. SAMEA Pemetrexed Diacid Sales by Type (2021-2026) & (doses) Table 218. SAMEA Pemetrexed Diacid Sales by Type (2027-2032) & (doses) Table 219. SAMEA Pemetrexed Diacid Sales Price by Type (2021-2026) & (US$/dose) Table 220. SAMEA Pemetrexed Diacid Sales Price by Type (2027-2032) & (US$/dose) Table 221. SAMEA Pemetrexed Diacid Revenue by Application (2021-2026) & (US$ Million) Table 222. SAMEA Pemetrexed Diacid Revenue by Application (2027-2032) & (US$ Million) Table 223. SAMEA Pemetrexed Diacid Sales by Application (2021-2026) & (doses) Table 224. SAMEA Pemetrexed Diacid Sales by Application (2027-2032) & (doses) Table 225. SAMEA Pemetrexed Diacid Sales Price by Application (2021-2026) & (US$/dose) Table 226. SAMEA Pemetrexed Diacid Sales Price by Application (2027-2032) & (US$/dose) Table 227. SAMEA Pemetrexed Diacid Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 228. SAMEA Pemetrexed Diacid Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 229. SAMEA Pemetrexed Diacid Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 230. SAMEA Pemetrexed Diacid Sales by Country (2021 VS 2025 VS 2032) & (doses) Table 231. SAMEA Pemetrexed Diacid Sales by Country (2021-2026) & (doses) Table 232. SAMEA Pemetrexed Diacid Sales by Country (2027-2032) & (doses) Table 233. SAMEA Pemetrexed Diacid Sales Price by Country (2021-2026) & (US$/dose) Table 234. SAMEA Pemetrexed Diacid Sales Price by Country (2027-2032) & (US$/dose) Table 235. Brazil Pemetrexed Diacid Revenue (2021-2032) & (US$ Million) Table 236. Argentina Pemetrexed Diacid Revenue (2021-2032) & (US$ Million) Table 237. Chile Pemetrexed Diacid Revenue (2021-2032) & (US$ Million) Table 238. Colombia Pemetrexed Diacid Revenue (2021-2032) & (US$ Million) Table 239. Peru Pemetrexed Diacid Revenue (2021-2032) & (US$ Million) Table 240. Saudi Arabia Pemetrexed Diacid Revenue (2021-2032) & (US$ Million) Table 241. Israel Pemetrexed Diacid Revenue (2021-2032) & (US$ Million) Table 242. UAE Pemetrexed Diacid Revenue (2021-2032) & (US$ Million) Table 243. Turkey Pemetrexed Diacid Revenue (2021-2032) & (US$ Million) Table 244. Iran Pemetrexed Diacid Revenue (2021-2032) & (US$ Million) Table 245. Egypt Pemetrexed Diacid Revenue (2021-2032) & (US$ Million) Table 246. Key Raw Materials Table 247. Raw Materials Key Suppliers Table 248. Pemetrexed Diacid Distributors List Table 249. Pemetrexed Diacid Customers List Table 250. Research Programs/Design for This Report Table 251. Authors List of This Report Table 252. Secondary Sources Table 253. Primary Sources List of Figures Figure 1. Pemetrexed Diacid Image Figure 2. Global Pemetrexed Diacid Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pemetrexed Diacid Market Size Share 2021 VS 2025 VS 2032 Figure 4. 500mg Injection Image Figure 5. 300mg Injection Image Figure 6. 200mg Injection Image Figure 7. 100mg Injection Image Figure 8. Global Pemetrexed Diacid Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Pemetrexed Diacid Market Size Share 2021 VS 2025 VS 2032 Figure 10. Mesothelioma Image Figure 11. Non-Small Cell Lung Cancer Image Figure 12. Others Image Figure 13. Global Pemetrexed Diacid Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Pemetrexed Diacid Revenue (2021-2032) & (US$ Million) Figure 15. Global Pemetrexed Diacid Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Pemetrexed Diacid Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Pemetrexed Diacid Revenue Market Share by Region (2021-2032) Figure 18. Global Pemetrexed Diacid Sales (2021-2032) & (doses) Figure 19. Global Pemetrexed Diacid Sales by Region: 2021 VS 2025 VS 2032 (doses) Figure 20. Global Pemetrexed Diacid Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Pemetrexed Diacid Sales YoY (2021-2032) & (doses) Figure 22. Europe Pemetrexed Diacid Sales YoY (2021-2032) & (doses) Figure 23. China Pemetrexed Diacid Sales YoY (2021-2032) & (doses) Figure 24. Asia (Excluding China) Pemetrexed Diacid Sales YoY (2021-2032) & (doses) Figure 25. South America, Middle East and Africa Pemetrexed Diacid Sales YoY (2021-2032) & (doses) Figure 26. Global Pemetrexed Diacid Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Pemetrexed Diacid Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Pemetrexed Diacid Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Pemetrexed Diacid Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Pemetrexed Diacid Revenue Market Share by Type (2021-2032) Figure 32. Global Pemetrexed Diacid Sales by Type (2021 VS 2025 VS 2032) & (doses) Figure 33. Global Pemetrexed Diacid Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Pemetrexed Diacid Sales Market Share by Type (2021-2032) Figure 35. Global Pemetrexed Diacid Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Pemetrexed Diacid Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Pemetrexed Diacid Revenue Market Share by Application (2021-2032) Figure 38. Global Pemetrexed Diacid Sales by Application (2021 VS 2025 VS 2032) & (doses) Figure 39. Global Pemetrexed Diacid Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Pemetrexed Diacid Sales Market Share by Application (2021-2032) Figure 41. North America Pemetrexed Diacid Revenue Share by Type (2021-2032) Figure 42. North America Pemetrexed Diacid Sales Share by Type (2021-2032) Figure 43. North America Pemetrexed Diacid Revenue Share by Application (2021-2032) Figure 44. North America Pemetrexed Diacid Sales Share by Application (2021-2032) Figure 45. North America Pemetrexed Diacid Revenue Share by Country (2021-2032) Figure 46. North America Pemetrexed Diacid Sales Share by Country (2021-2032) Figure 47. Europe Pemetrexed Diacid Revenue Share by Type (2021-2032) Figure 48. Europe Pemetrexed Diacid Sales Share by Type (2021-2032) Figure 49. Europe Pemetrexed Diacid Revenue Share by Application (2021-2032) Figure 50. Europe Pemetrexed Diacid Sales Share by Application (2021-2032) Figure 51. Europe Pemetrexed Diacid Revenue Share by Country (2021-2032) Figure 52. Europe Pemetrexed Diacid Sales Share by Country (2021-2032) Figure 53. China Pemetrexed Diacid Revenue Share by Type (2021-2032) Figure 54. China Pemetrexed Diacid Sales Share by Type (2021-2032) Figure 55. China Pemetrexed Diacid Revenue Share by Application (2021-2032) Figure 56. China Pemetrexed Diacid Sales Share by Application (2021-2032) Figure 57. Asia Pemetrexed Diacid Revenue Share by Type (2021-2032) Figure 58. Asia Pemetrexed Diacid Sales Share by Type (2021-2032) Figure 59. Asia Pemetrexed Diacid Revenue Share by Application (2021-2032) Figure 60. Asia Pemetrexed Diacid Sales Share by Application (2021-2032) Figure 61. Asia Pemetrexed Diacid Revenue Share by Country (2021-2032) Figure 62. Asia Pemetrexed Diacid Sales Share by Country (2021-2032) Figure 63. SAMEA Pemetrexed Diacid Revenue Share by Type (2021-2032) Figure 64. SAMEA Pemetrexed Diacid Sales Share by Type (2021-2032) Figure 65. SAMEA Pemetrexed Diacid Revenue Share by Application (2021-2032) Figure 66. SAMEA Pemetrexed Diacid Sales Share by Application (2021-2032) Figure 67. SAMEA Pemetrexed Diacid Revenue Share by Country (2021-2032) Figure 68. SAMEA Pemetrexed Diacid Sales Share by Country (2021-2032) Figure 69. Pemetrexed Diacid Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Pemetrexed Diacid Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • 500mg Injection
  • 300mg Injection
  • 200mg Injection
  • 100mg Injection
Applications
  • Mesothelioma
  • Non-Small Cell Lung Cancer
  • Others
Companies covered
  • Qilu Pharma
  • Nanjing Pharmaceutical Factory Co., Ltd.
  • Lianyungang Tengfa Bio-tech Co., Ltd.
  • Eli Lilly and Company
  • United Biotech India Pvt.Ltd.
  • Pemgem
  • Onkos
  • Natco Pharma Ltd
  • Emcure
  • Cytotoxic
  • ChemOthersapy
  • Beacon Pharma
  • Actiza Parma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Pemetrexed Diacid Market by Type
  3. 1.2.1 Global Pemetrexed Diacid Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 500mg Injection
  5. 1.2.3 300mg Injection
  6. 1.2.4 200mg Injection
  7. 1.2.5 100mg Injection
  8. 1.3 Pemetrexed Diacid Market by Application
  9. 1.3.1 Global Pemetrexed Diacid Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Mesothelioma
  11. 1.3.3 Non-Small Cell Lung Cancer
  12. 1.3.4 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Pemetrexed Diacid Market Dynamics
  1. 2.1 Pemetrexed Diacid Industry Trends
  2. 2.2 Pemetrexed Diacid Industry Drivers
  3. 2.3 Pemetrexed Diacid Industry Opportunities and Challenges
  4. 2.4 Pemetrexed Diacid Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Pemetrexed Diacid Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Pemetrexed Diacid Revenue by Region
  3. 3.2.1 Global Pemetrexed Diacid Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Pemetrexed Diacid Revenue by Region (2021-2026)
  5. 3.2.3 Global Pemetrexed Diacid Revenue by Region (2027-2032)
  6. 3.2.4 Global Pemetrexed Diacid Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Pemetrexed Diacid Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Pemetrexed Diacid Sales by Region
  9. 3.4.1 Global Pemetrexed Diacid Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Pemetrexed Diacid Sales by Region (2021-2026)
  11. 3.4.3 Global Pemetrexed Diacid Sales by Region (2027-2032)
  12. 3.4.4 Global Pemetrexed Diacid Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Pemetrexed Diacid Revenue by Manufacturers
  2. 4.1.1 Global Pemetrexed Diacid Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Pemetrexed Diacid Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Pemetrexed Diacid Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Pemetrexed Diacid Sales by Manufacturers
  6. 4.2.1 Global Pemetrexed Diacid Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Pemetrexed Diacid Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Pemetrexed Diacid Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Pemetrexed Diacid Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Pemetrexed Diacid Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Pemetrexed Diacid Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Pemetrexed Diacid Manufacturers, Product Type & Application
  13. 4.7 Global Pemetrexed Diacid Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Pemetrexed Diacid Market CR5 and HHI
  16. 4.8.2 2025 Pemetrexed Diacid Tier 1, Tier 2, and Tier 3
5 Pemetrexed Diacid Market by Type
  1. 5.1 Global Pemetrexed Diacid Revenue by Type
  2. 5.1.1 Global Pemetrexed Diacid Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Pemetrexed Diacid Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Pemetrexed Diacid Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Pemetrexed Diacid Sales by Type
  6. 5.2.1 Global Pemetrexed Diacid Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pemetrexed Diacid Sales by Type (2021-2032) & (doses)
  8. 5.2.3 Global Pemetrexed Diacid Sales Market Share by Type (2021-2032)
  9. 5.3 Global Pemetrexed Diacid Price by Type
6 Pemetrexed Diacid Market by Application
  1. 6.1 Global Pemetrexed Diacid Revenue by Application
  2. 6.1.1 Global Pemetrexed Diacid Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Pemetrexed Diacid Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Pemetrexed Diacid Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Pemetrexed Diacid Sales by Application
  6. 6.2.1 Global Pemetrexed Diacid Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Pemetrexed Diacid Sales by Application (2021-2032) & (doses)
  8. 6.2.3 Global Pemetrexed Diacid Sales Market Share by Application (2021-2032)
  9. 6.3 Global Pemetrexed Diacid Price by Application
7 Company Profiles
  1. 7.1 Qilu Pharma
  2. 7.1.1 Qilu Pharma Company Information
  3. 7.1.2 Qilu Pharma Business Overview
  4. 7.1.3 Qilu Pharma Pemetrexed Diacid Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Qilu Pharma Pemetrexed Diacid Product Portfolio
  6. 7.1.5 Qilu Pharma Recent Developments
  7. 7.2 Nanjing Pharmaceutical Factory Co., Ltd.
  8. 7.2.1 Nanjing Pharmaceutical Factory Co., Ltd. Company Information
  9. 7.2.2 Nanjing Pharmaceutical Factory Co., Ltd. Business Overview
  10. 7.2.3 Nanjing Pharmaceutical Factory Co., Ltd. Pemetrexed Diacid Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Nanjing Pharmaceutical Factory Co., Ltd. Pemetrexed Diacid Product Portfolio
  12. 7.2.5 Nanjing Pharmaceutical Factory Co., Ltd. Recent Developments
  13. 7.3 Lianyungang Tengfa Bio-tech Co., Ltd.
  14. 7.3.1 Lianyungang Tengfa Bio-tech Co., Ltd. Company Information
  15. 7.3.2 Lianyungang Tengfa Bio-tech Co., Ltd. Business Overview
  16. 7.3.3 Lianyungang Tengfa Bio-tech Co., Ltd. Pemetrexed Diacid Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Lianyungang Tengfa Bio-tech Co., Ltd. Pemetrexed Diacid Product Portfolio
  18. 7.3.5 Lianyungang Tengfa Bio-tech Co., Ltd. Recent Developments
  19. 7.4 Eli Lilly and Company
  20. 7.4.1 Eli Lilly and Company Company Information
  21. 7.4.2 Eli Lilly and Company Business Overview
  22. 7.4.3 Eli Lilly and Company Pemetrexed Diacid Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Eli Lilly and Company Pemetrexed Diacid Product Portfolio
  24. 7.4.5 Eli Lilly and Company Recent Developments
  25. 7.5 United Biotech India Pvt.Ltd.
  26. 7.5.1 United Biotech India Pvt.Ltd. Company Information
  27. 7.5.2 United Biotech India Pvt.Ltd. Business Overview
  28. 7.5.3 United Biotech India Pvt.Ltd. Pemetrexed Diacid Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 United Biotech India Pvt.Ltd. Pemetrexed Diacid Product Portfolio
  30. 7.5.5 United Biotech India Pvt.Ltd. Recent Developments
  31. 7.6 Pemgem
  32. 7.6.1 Pemgem Company Information
  33. 7.6.2 Pemgem Business Overview
  34. 7.6.3 Pemgem Pemetrexed Diacid Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Pemgem Pemetrexed Diacid Product Portfolio
  36. 7.6.5 Pemgem Recent Developments
  37. 7.7 Onkos
  38. 7.7.1 Onkos Company Information
  39. 7.7.2 Onkos Business Overview
  40. 7.7.3 Onkos Pemetrexed Diacid Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Onkos Pemetrexed Diacid Product Portfolio
  42. 7.7.5 Onkos Recent Developments
  43. 7.8 Natco Pharma Ltd
  44. 7.8.1 Natco Pharma Ltd Company Information
  45. 7.8.2 Natco Pharma Ltd Business Overview
  46. 7.8.3 Natco Pharma Ltd Pemetrexed Diacid Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Natco Pharma Ltd Pemetrexed Diacid Product Portfolio
  48. 7.8.5 Natco Pharma Ltd Recent Developments
  49. 7.9 Emcure
  50. 7.9.1 Emcure Company Information
  51. 7.9.2 Emcure Business Overview
  52. 7.9.3 Emcure Pemetrexed Diacid Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Emcure Pemetrexed Diacid Product Portfolio
  54. 7.9.5 Emcure Recent Developments
  55. 7.10 Cytotoxic
  56. 7.10.1 Cytotoxic Company Information
  57. 7.10.2 Cytotoxic Business Overview
  58. 7.10.3 Cytotoxic Pemetrexed Diacid Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Cytotoxic Pemetrexed Diacid Product Portfolio
  60. 7.10.5 Cytotoxic Recent Developments
  61. 7.11 ChemOthersapy
  62. 7.11.1 ChemOthersapy Company Information
  63. 7.11.2 ChemOthersapy Business Overview
  64. 7.11.3 ChemOthersapy Pemetrexed Diacid Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 ChemOthersapy Pemetrexed Diacid Product Portfolio
  66. 7.11.5 ChemOthersapy Recent Developments
  67. 7.12 Beacon Pharma
  68. 7.12.1 Beacon Pharma Company Information
  69. 7.12.2 Beacon Pharma Business Overview
  70. 7.12.3 Beacon Pharma Pemetrexed Diacid Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Beacon Pharma Pemetrexed Diacid Product Portfolio
  72. 7.12.5 Beacon Pharma Recent Developments
  73. 7.13 Actiza Parma
  74. 7.13.1 Actiza Parma Company Information
  75. 7.13.2 Actiza Parma Business Overview
  76. 7.13.3 Actiza Parma Pemetrexed Diacid Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Actiza Parma Pemetrexed Diacid Product Portfolio
  78. 7.13.5 Actiza Parma Recent Developments
8 North America
  1. 8.1 North America Pemetrexed Diacid Market Size by Type
  2. 8.1.1 North America Pemetrexed Diacid Revenue by Type (2021-2032)
  3. 8.1.2 North America Pemetrexed Diacid Sales by Type (2021-2032)
  4. 8.1.3 North America Pemetrexed Diacid Price by Type (2021-2032)
  5. 8.2 North America Pemetrexed Diacid Market Size by Application
  6. 8.2.1 North America Pemetrexed Diacid Revenue by Application (2021-2032)
  7. 8.2.2 North America Pemetrexed Diacid Sales by Application (2021-2032)
  8. 8.2.3 North America Pemetrexed Diacid Price by Application (2021-2032)
  9. 8.3 North America Pemetrexed Diacid Market Size by Country
  10. 8.3.1 North America Pemetrexed Diacid Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Pemetrexed Diacid Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Pemetrexed Diacid Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Pemetrexed Diacid Market Size by Type
  2. 9.1.1 Europe Pemetrexed Diacid Revenue by Type (2021-2032)
  3. 9.1.2 Europe Pemetrexed Diacid Sales by Type (2021-2032)
  4. 9.1.3 Europe Pemetrexed Diacid Price by Type (2021-2032)
  5. 9.2 Europe Pemetrexed Diacid Market Size by Application
  6. 9.2.1 Europe Pemetrexed Diacid Revenue by Application (2021-2032)
  7. 9.2.2 Europe Pemetrexed Diacid Sales by Application (2021-2032)
  8. 9.2.3 Europe Pemetrexed Diacid Price by Application (2021-2032)
  9. 9.3 Europe Pemetrexed Diacid Market Size by Country
  10. 9.3.1 Europe Pemetrexed Diacid Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Pemetrexed Diacid Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Pemetrexed Diacid Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Pemetrexed Diacid Market Size by Type
  2. 10.1.1 China Pemetrexed Diacid Revenue by Type (2021-2032)
  3. 10.1.2 China Pemetrexed Diacid Sales by Type (2021-2032)
  4. 10.1.3 China Pemetrexed Diacid Price by Type (2021-2032)
  5. 10.2 China Pemetrexed Diacid Market Size by Application
  6. 10.2.1 China Pemetrexed Diacid Revenue by Application (2021-2032)
  7. 10.2.2 China Pemetrexed Diacid Sales by Application (2021-2032)
  8. 10.2.3 China Pemetrexed Diacid Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Pemetrexed Diacid Market Size by Type
  2. 11.1.1 Asia Pemetrexed Diacid Revenue by Type (2021-2032)
  3. 11.1.2 Asia Pemetrexed Diacid Sales by Type (2021-2032)
  4. 11.1.3 Asia Pemetrexed Diacid Price by Type (2021-2032)
  5. 11.2 Asia Pemetrexed Diacid Market Size by Application
  6. 11.2.1 Asia Pemetrexed Diacid Revenue by Application (2021-2032)
  7. 11.2.2 Asia Pemetrexed Diacid Sales by Application (2021-2032)
  8. 11.2.3 Asia Pemetrexed Diacid Price by Application (2021-2032)
  9. 11.3 Asia Pemetrexed Diacid Market Size by Country
  10. 11.3.1 Asia Pemetrexed Diacid Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Pemetrexed Diacid Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Pemetrexed Diacid Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Pemetrexed Diacid Market Size by Type
  2. 12.1.1 SAMEA Pemetrexed Diacid Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Pemetrexed Diacid Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Pemetrexed Diacid Price by Type (2021-2032)
  5. 12.2 SAMEA Pemetrexed Diacid Market Size by Application
  6. 12.2.1 SAMEA Pemetrexed Diacid Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Pemetrexed Diacid Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Pemetrexed Diacid Price by Application (2021-2032)
  9. 12.3 SAMEA Pemetrexed Diacid Market Size by Country
  10. 12.3.1 SAMEA Pemetrexed Diacid Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Pemetrexed Diacid Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Pemetrexed Diacid Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Pemetrexed Diacid Value Chain Analysis
  2. 13.1.1 Pemetrexed Diacid Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Pemetrexed Diacid Production Mode & Process
  6. 13.2 Pemetrexed Diacid Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Pemetrexed Diacid Distributors
  9. 13.2.3 Pemetrexed Diacid Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst